Logo image of 8TI.DE

STELLANTIS NV (8TI.DE) Stock Fundamental Analysis

Europe - FRA:8TI - NL00150001Q9 - Common Stock

8.376 EUR
-0.4 (-4.59%)
Last: 10/14/2025, 7:00:00 PM
Fundamental Rating

2

Overall 8TI gets a fundamental rating of 2 out of 10. We evaluated 8TI against 29 industry peers in the Automobiles industry. 8TI may be in some trouble as it scores bad on both profitability and health. 8TI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year 8TI has reported negative net income.
In the past year 8TI has reported a negative cash flow from operations.
In the past 5 years 8TI has always been profitable.
8TI had a positive operating cash flow in each of the past 5 years.
8TI.DE Yearly Net Income VS EBIT VS OCF VS FCF8TI.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

1.2 Ratios

Looking at the Return On Assets, with a value of -1.19%, 8TI is doing worse than 68.97% of the companies in the same industry.
8TI has a Return On Equity of -3.27%. This is in the lower half of the industry: 8TI underperforms 68.97% of its industry peers.
Industry RankSector Rank
ROA -1.19%
ROE -3.27%
ROIC N/A
ROA(3y)6.95%
ROA(5y)5.83%
ROE(3y)17.6%
ROE(5y)15.66%
ROIC(3y)N/A
ROIC(5y)N/A
8TI.DE Yearly ROA, ROE, ROIC8TI.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

In the last couple of years the Profit Margin of 8TI has declined.
In the last couple of years the Operating Margin of 8TI has declined.
8TI's Gross Margin of 7.74% is on the low side compared to the rest of the industry. 8TI is outperformed by 86.21% of its industry peers.
8TI's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for 8TI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.74%
OM growth 3Y-28.95%
OM growth 5Y-7.06%
PM growth 3Y-28.4%
PM growth 5Y-10.63%
GM growth 3Y-13.66%
GM growth 5Y-1.49%
8TI.DE Yearly Profit, Operating, Gross Margins8TI.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

2

2. Health

2.1 Basic Checks

8TI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 8TI has been reduced compared to 1 year ago.
Compared to 5 years ago, 8TI has more shares outstanding
Compared to 1 year ago, 8TI has a worse debt to assets ratio.
8TI.DE Yearly Shares Outstanding8TI.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
8TI.DE Yearly Total Debt VS Total Assets8TI.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

2.2 Solvency

Based on the Altman-Z score of 1.34, we must say that 8TI is in the distress zone and has some risk of bankruptcy.
8TI has a better Altman-Z score (1.34) than 65.52% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that 8TI is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.38, 8TI is doing good in the industry, outperforming 65.52% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 1.34
ROIC/WACCN/A
WACC6.89%
8TI.DE Yearly LT Debt VS Equity VS FCF8TI.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B

2.3 Liquidity

8TI has a Current Ratio of 1.06. This is a normal value and indicates that 8TI is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of 8TI (1.06) is worse than 68.97% of its industry peers.
8TI has a Quick Ratio of 1.06. This is a bad value and indicates that 8TI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.77, 8TI is doing worse than 75.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.77
8TI.DE Yearly Current Assets VS Current Liabilites8TI.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

More info and screens

3

3. Growth

3.1 Past

8TI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -118.93%.
Measured over the past years, 8TI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.26% on average per year.
Looking at the last year, 8TI shows a very negative growth in Revenue. The Revenue has decreased by -17.07% in the last year.
Measured over the past years, 8TI shows a small growth in Revenue. The Revenue has been growing by 7.72% on average per year.
EPS 1Y (TTM)-118.93%
EPS 3Y-25.78%
EPS 5Y-15.26%
EPS Q2Q%-141.95%
Revenue 1Y (TTM)-17.07%
Revenue growth 3Y1.64%
Revenue growth 5Y7.72%
Sales Q2Q%71.49%

3.2 Future

8TI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.96% yearly.
Based on estimates for the next years, 8TI will show a small growth in Revenue. The Revenue will grow by 3.49% on average per year.
EPS Next Y-83%
EPS Next 2Y-16.54%
EPS Next 3Y-1.94%
EPS Next 5Y7.96%
Revenue Next Year-2.79%
Revenue Next 2Y1.13%
Revenue Next 3Y1.93%
Revenue Next 5Y3.49%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
8TI.DE Yearly Revenue VS Estimates8TI.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50B 100B 150B 200B
8TI.DE Yearly EPS VS Estimates8TI.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for 8TI. In the last year negative earnings were reported.
8TI is valuated cheaply with a Price/Forward Earnings ratio of 5.28.
Based on the Price/Forward Earnings ratio, 8TI is valued a bit cheaper than 72.41% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of 8TI to the average of the S&P500 Index (22.99), we can say 8TI is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 5.28
8TI.DE Price Earnings VS Forward Price Earnings8TI.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as 8TI.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.51
8TI.DE Per share data8TI.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.54%
EPS Next 3Y-1.94%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for 8TI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

STELLANTIS NV

FRA:8TI (10/14/2025, 7:00:00 PM)

8.376

-0.4 (-4.59%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)07-21 2025-07-21/bmo
Earnings (Next)10-30 2025-10-30
Inst Owners50.06%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap24.26B
Analysts68
Price Target9.36 (11.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.58
Dividend Growth(5Y)0.29%
DP-81.93%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.2%
PT rev (3m)-13.56%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-47.48%
EPS NY rev (3m)-81.29%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.27%
Revenue NY rev (3m)-3.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.28
P/S 0.17
P/FCF N/A
P/OCF N/A
P/B 0.33
P/tB 1.04
EV/EBITDA 6.51
EPS(TTM)-0.83
EYN/A
EPS(NY)1.58
Fwd EY18.92%
FCF(TTM)-4.68
FCFYN/A
OCF(TTM)-1.05
OCFYN/A
SpS50.46
BVpS25.25
TBVpS8.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.19%
ROE -3.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.74%
FCFM N/A
ROA(3y)6.95%
ROA(5y)5.83%
ROE(3y)17.6%
ROE(5y)15.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)13.77%
ROCE(5y)12.77%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-28.95%
OM growth 5Y-7.06%
PM growth 3Y-28.4%
PM growth 5Y-10.63%
GM growth 3Y-13.66%
GM growth 5Y-1.49%
F-Score1
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA 5.91
Cap/Depr 145.84%
Cap/Sales 7.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.77
Altman-Z 1.34
F-Score1
WACC6.89%
ROIC/WACCN/A
Cap/Depr(3y)140.23%
Cap/Depr(5y)152.03%
Cap/Sales(3y)5.82%
Cap/Sales(5y)6.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-118.93%
EPS 3Y-25.78%
EPS 5Y-15.26%
EPS Q2Q%-141.95%
EPS Next Y-83%
EPS Next 2Y-16.54%
EPS Next 3Y-1.94%
EPS Next 5Y7.96%
Revenue 1Y (TTM)-17.07%
Revenue growth 3Y1.64%
Revenue growth 5Y7.72%
Sales Q2Q%71.49%
Revenue Next Year-2.79%
Revenue Next 2Y1.13%
Revenue Next 3Y1.93%
Revenue Next 5Y3.49%
EBIT growth 1Y-114.76%
EBIT growth 3Y-27.78%
EBIT growth 5Y0.11%
EBIT Next Year17.69%
EBIT Next 3Y26.55%
EBIT Next 5Y21.37%
FCF growth 1Y-193.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-112.94%
OCF growth 3Y-40.45%
OCF growth 5Y-18.8%